Brevan Howard Capital Management LP Haemonetics Corp Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Haemonetics Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 4,920 shares of HAE stock, worth $301,645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,920
Previous 3,809
29.17%
Holding current value
$301,645
Previous $315,000
25.4%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
344Shares Held
55.1MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$365 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$318 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$272 Million0.08% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$247 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.94MShares$242 Million0.06% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.15B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...